Feasibility Study of Metronomic Chemotherapy for Locally Advanced Her2- Positive Breast Cancer (TraQ-Me 01)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Locally Advanced HER2-positive Breast Cancer
Interventions: DEVICE: Drug: Paclitaxel; trastuzumab; doxorrubicin; cyclophosphamide
Sponsor: Instituto do Cancer do Estado de São Paulo
Collaborators: Fundação Faculdade de Medicina